e.g. mhealth
Search Results (1 to 10 of 510 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 116 JMIR Diabetes
- 90 Journal of Medical Internet Research
- 80 JMIR Formative Research
- 72 JMIR Research Protocols
- 32 JMIR mHealth and uHealth
- 25 JMIR Medical Informatics
- 17 JMIR Public Health and Surveillance
- 14 JMIR Human Factors
- 9 Iproceedings
- 9 JMIR Pediatrics and Parenting
- 9 JMIRx Med
- 7 JMIR Aging
- 6 JMIR Cardio
- 5 JMIR Serious Games
- 4 Interactive Journal of Medical Research
- 4 JMIR AI
- 3 Asian/Pacific Island Nursing Journal
- 2 JMIR Mental Health
- 2 JMIR Nursing
- 2 Journal of Participatory Medicine
- 1 JMIR Bioinformatics and Biotechnology
- 1 JMIR Biomedical Engineering
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Data
- 0 JMIR Dermatology
- 0 JMIR Perioperative Medicine
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Diabetic retinopathy (DR) is a prevalent and severe microvascular complication of diabetes mellitus (DM) [1]. In India, 10.9% (7.2%‐16.3%) of individuals aged 65 years and above with diabetes have DR, with 2.3% (1.2%‐4.4%) suffering from vision-threatening diabetic retinopathy (VTDR) [1], characterized by severe retinopathy or macular edema [2]. DR is typically asymptomatic in its early stages, and it can lead to visual impairment or blindness if left untreated [3].
JMIR Form Res 2025;9:e67047
Download Citation: END BibTex RIS
According to the Guideline for the Prevention and Treatment of Type 2 Diabetes Mellitus in China (2020 Edition) [1], the prevalence of diabetes in China has surged from 0.67% in 1980 to 11.2% in 2015-2017 [2,3]. Diabetes management in China faces significant challenges, particularly in rural areas where awareness, treatment, and control rates remain low.
JMIR Res Protoc 2025;14:e58951
Download Citation: END BibTex RIS
Digital therapeutics (DTx), defined as evidence-based therapeutic interventions that are driven by high-quality software programs to treat, manage, or prevent a disease or disorder, can be effective in treating diabetes by inducing behavior changes [1]. However, studies of DTx generally do not explore the implications of the underlying behavior change theory.
JMIR Form Res 2025;9:e60221
Download Citation: END BibTex RIS
There are significant racial and ethnic disparities in the prevalence, morbidity, and mortality of type 2 diabetes (T2 D). Despite medical advances and increased access to medical care, these disparities persist. Racial or ethnic minorities are more likely to have poor glycemic control [1], develop diabetes-related complications [2], and are 1.5-2.3 times more likely to die from diabetes than White individuals [3].
JMIR Form Res 2025;9:e67293
Download Citation: END BibTex RIS
Adults with diabetes can significantly lower their risk of diabetes complications such as nerve damage, kidney failure, blindness, myocardial infarction, and stroke by maintaining healthy daily diabetes self-management behaviors [1-3].
JMIR Diabetes 2025;10:e64505
Download Citation: END BibTex RIS
The study cohort was identified using electronic health records (EHRs) and included adult patients (aged 18 years and older) with diabetes mellitus who had at least 1 primary care or endocrinology encounter between July 1, 2020, and March 31, 2021 (hereafter referred to as the study period). Participants were required to have a diagnosis of diabetes prior to the beginning of the study period.
J Med Internet Res 2025;27:e64635
Download Citation: END BibTex RIS
Diabetes is a significant global health issue, with the number of people affected by the disease continually rising [1]. According to the International Diabetes Federation Diabetes Atlas, the global number of people with diabetes reached 537 million in 2021 and is expected to continue rising, reaching an estimated 783 million by 2045 [2]. The most prevalent form of diabetes is type 2 diabetes, which affects more than 90% of all individuals with diabetes [2].
JMIR Hum Factors 2025;12:e48226
Download Citation: END BibTex RIS
A study among patients with diabetes reported that time without medication was reduced for those who exclusively used the refill function of the portal compared to those who did not use it [4]. Nonadherence to statins reduced by 6% (95% CI 4%‐7%) among patients with diabetes exclusively using the refill function compared to nonusers of the portal [5].
JMIR Med Inform 2025;13:e50294
Download Citation: END BibTex RIS
Evidence from randomized trials of telemedicine interventions for type 2 diabetes (T2 D) demonstrates that remote review of blood glucose by care teams [7,8]; active remote medication adjustment [8,9]; patient engagement between visits via phone, text message, or portals [9]; multidisciplinary team involvement in virtual care [8]; and remote diabetes self-management education and support services [10-12] are associated with the greatest hemoglobin A1c improvement and may support diabetes care quality.
JMIR Diabetes 2025;10:e60765
Download Citation: END BibTex RIS
Diabetes is a serious metabolic condition in which the body experiences elevated blood glucose levels, which can result in serious complications such as cardiovascular disease, kidney disease, stroke, eye disease, foot ulcers, nerve damage, and amputation. The World Health Organization [1] states that high blood glucose levels are the third leading cause of premature mortality. Type 2 diabetes (T2 D) is characterized by insulin resistance or insufficient production of insulin.
JMIR Form Res 2025;9:e51154
Download Citation: END BibTex RIS